Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 48% ± 17% | |
astrocyte | 11 studies | 41% ± 19% | |
macrophage | 8 studies | 31% ± 13% | |
oligodendrocyte precursor cell | 8 studies | 34% ± 14% | |
endothelial cell | 8 studies | 23% ± 2% | |
myeloid cell | 7 studies | 32% ± 15% | |
microglial cell | 7 studies | 36% ± 6% | |
adipocyte | 6 studies | 27% ± 8% | |
classical monocyte | 5 studies | 22% ± 6% | |
GABAergic neuron | 5 studies | 25% ± 3% | |
epithelial cell | 5 studies | 31% ± 15% | |
dendritic cell | 5 studies | 29% ± 7% | |
endothelial cell of lymphatic vessel | 4 studies | 24% ± 5% | |
glutamatergic neuron | 4 studies | 36% ± 10% | |
interneuron | 4 studies | 36% ± 17% | |
retinal pigment epithelial cell | 3 studies | 57% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1370.59 | 653 / 653 | 98% | 14.94 | 593 / 605 |
breast | 100% | 2486.61 | 459 / 459 | 98% | 18.23 | 1093 / 1118 |
lung | 100% | 1142.23 | 577 / 578 | 96% | 5.08 | 1113 / 1155 |
brain | 99% | 1632.78 | 2610 / 2642 | 97% | 6.00 | 685 / 705 |
prostate | 100% | 1104.16 | 245 / 245 | 96% | 5.96 | 481 / 502 |
kidney | 100% | 1029.96 | 89 / 89 | 95% | 5.17 | 855 / 901 |
pancreas | 100% | 1161.73 | 328 / 328 | 94% | 4.20 | 167 / 178 |
esophagus | 100% | 645.95 | 1445 / 1445 | 93% | 5.29 | 171 / 183 |
skin | 100% | 1216.74 | 1808 / 1809 | 92% | 13.21 | 434 / 472 |
stomach | 100% | 721.34 | 359 / 359 | 91% | 4.36 | 260 / 286 |
liver | 100% | 898.87 | 226 / 226 | 90% | 5.00 | 367 / 406 |
uterus | 100% | 1012.18 | 170 / 170 | 90% | 4.13 | 411 / 459 |
intestine | 100% | 893.49 | 966 / 966 | 89% | 4.16 | 469 / 527 |
adrenal gland | 100% | 764.16 | 258 / 258 | 83% | 3.19 | 192 / 230 |
ovary | 100% | 971.92 | 180 / 180 | 82% | 3.08 | 352 / 430 |
bladder | 100% | 631.00 | 21 / 21 | 81% | 3.32 | 410 / 504 |
spleen | 100% | 915.92 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 974.21 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 965.84 | 1333 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 4.89 | 42 / 45 |
heart | 92% | 428.19 | 794 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 320.33 | 732 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 399.70 | 765 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 3.15 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 66% | 4.48 | 53 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0001558 | Biological process | regulation of cell growth |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030334 | Biological process | regulation of cell migration |
GO_2001240 | Biological process | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0051090 | Biological process | regulation of DNA-binding transcription factor activity |
GO_0006468 | Biological process | protein phosphorylation |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0005829 | Cellular component | cytosol |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005246 | Molecular function | calcium channel regulator activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0017081 | Molecular function | chloride channel regulator activity |
GO_0015459 | Molecular function | potassium channel regulator activity |
GO_0005524 | Molecular function | ATP binding |
GO_0017080 | Molecular function | sodium channel regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SGK3 |
Protein name | Serum/glucocorticoid regulated kinase family member 3 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) |
Synonyms | SGKL CISK |
Description | FUNCTION: Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, proliferation, survival and migration. Up-regulates Na(+) channels: SCNN1A/ENAC and SCN5A, K(+) channels: KCNA3/KV1.3, KCNE1, KCNQ1 and KCNH2/HERG, epithelial Ca(2+) channels: TRPV5 and TRPV6, chloride channel: BSND, creatine transporter: SLC6A8, Na(+)/dicarboxylate cotransporter: SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter: SLC34A2/NAPI-2B, amino acid transporters: SLC1A5/ASCT2 and SLC6A19, glutamate transporters: SLC1A3/EAAT1, SLC1A6/EAAT4 and SLC1A7/EAAT5, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase. Plays a role in the regulation of renal tubular phosphate transport and bone density. Phosphorylates NEDD4L and GSK3B. Positively regulates ER transcription activity through phosphorylation of FLII. Negatively regulates the function of ITCH/AIP4 via its phosphorylation and thereby prevents CXCR4 from being efficiently sorted to lysosomes. . |
Accessions | ENST00000345714.8 [Q96BR1-1] E5RK28 E5RJV7 ENST00000521960.5 ENST00000522629.5 E5RHY6 E5RHX2 ENST00000518388.5 E5RHR8 ENST00000520976.5 [Q96BR1-2] ENST00000519396.5 ENST00000396596.2 [Q96BR1-1] ENST00000522398.5 [Q96BR1-1] ENST00000521198.7 [Q96BR1-1] ENST00000521152.5 Q96BR1 |